PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 9 days 15 hours 55 minutes
Back to Basics: What You Need to Know to Identify BCC in Your Patients
Back to Basics: What You Need to Know to Identify BCC in Your Patients
Practical Implications of Recent Clinical Advances on the Treatment of Spondyloarthritis: Updates From Madrid
Go online to www.peervoice.com/VTW860 to view the entire programme with slides.
Optimizing Strategies for Switching Antipsychotics in Schizophrenia
Optimizing Strategies for Switching Antipsychotics in Schizophrenia
Expert Perspectives: Weighing the Evidence for Current and Emerging Therapies in the Management of Advanced Renal Cell Carcinoma
Go online to www.peervoice.com/KSP860 to view the entire programme with slides.
Multidisciplinary Perspectives on the Future of Pancreatic Cancer Treatment Through the Disease Course: Piecing the Information Together
Go online to www.peervoice.com/WVH860 to view the entire programme with slides.
Journal Club: ORAL Strategy—New Insights on Biologic Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
Go online to www.peervoice.com/KFT860 to view the entire programme with slides.
Treating Adult ALL in Canada: Expert Guidance on Updated Treatment Protocols
Treating Adult ALL in Canada: Expert Guidance on Updated Treatment Protocols
Expert Perspectives on Management of EGFR-Mutated NSCLC: Overcoming Resistance to Ensure Active Lines of Therapy
Go online to www.peervoice.com/UVS860 to view the entire programme with slides.
Using the Data to Optimize Front-Line Immunotherapy in Advanced Melanoma
Using the Data to Optimize Front-Line Immunotherapy in Advanced Melanoma
Updates From Madrid: New Findings on IL-6 Inhibitors for Treatment of Rheumatoid Arthritis
Go online to www.peervoice.com/TWF860 to view the entire programme with slides.